The following Investment Committee paper focuses on a proposal for a leveraged buyout on Elekta AB, a key player in the global radiotherapy market which sells in more than 120 countries. In fact, this paper develops a set of value creation strategies (with an emphasis on the Buy & Build strategy) through a detailed analysis of the radiotherapy market and of the competitive advantages of the company. Subsequently, a capital structure is suggested by assessing past buyout transactions in the healthcare sector and by leveraging the bank case. Finally, the exit returns are estimated complying with industry threshold and a range of exit strategies are analyzed
